Displaying 1 - 12 of 27

Display:

12 24 48

Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Welcome and a journey back to 1992

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Personal perspectives: What is the most significant advance in the last 10 years?

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Personal priorities

Webcasts

View

Metabolism, Alcohol & Toxicity

Wrap-up

Webcasts

View

Metabolism, Alcohol & Toxicity

Introduction

Webcasts

View

Metabolism, Alcohol & Toxicity

Q&A

Webcasts

View

Metabolism, Alcohol & Toxicity

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts

View

Metabolism, Alcohol & Toxicity

Clinical cases presentation and discussion

Webcasts

View

Metabolism, Alcohol & Toxicity

FAST score for identification of active fibrotic NASH

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Unmet needs in PBC: the patient perspective

Webcasts

View

Displaying 1 - 12 of 27

Display:

12 24 48